Fescharek R - Search Results

1

OPV vs IPV--could placental immunity reduce the number of vaccine-associated paralytic poliomyelitis?

Fescharek R, Budde RK, Arras C. Fescharek R, et al. Vaccine. 1997 Nov;15(16):1707-8. doi: 10.1016/s0264-410x(97)85581-8. Vaccine. 1997. PMID: 9364670 No abstract available.

2

Do specific hyperimmunoglobulins aggravate clinical course of tick-borne encephalitis?

Arras C, Fescharek R, Gregersen JP. Arras C, et al. Among authors: fescharek r. Lancet. 1996 May 11;347(9011):1331. doi: 10.1016/s0140-6736(96)90977-0. Lancet. 1996. PMID: 8622522 No abstract available.

3

Measles-mumps vaccination in the FRG: an empirical analysis after 14 years of use. I. Efficacy and analysis of vaccine failures.

Fescharek R, Quast U, Maass G, Merkle W, Schwarz S. Fescharek R, et al. Vaccine. 1990 Aug;8(4):333-6. doi: 10.1016/0264-410x(90)90090-9. Vaccine. 1990. PMID: 2396472

4

Measles-mumps vaccination in the FRG: an empirical analysis after 14 years of use. II. Tolerability and analysis of spontaneously reported side effects.

Fescharek R, Quast U, Maass G, Merkle W, Schwarz S. Fescharek R, et al. Vaccine. 1990 Oct;8(5):446-56. doi: 10.1016/0264-410x(90)90245-h. Vaccine. 1990. PMID: 2251871

5

Dangers of immunosuppressive treatments in postexposure rabies prophylaxis.

Fescharek R, Franke V. Fescharek R, et al. Vaccine. 1990 Apr;8(2):172-3. doi: 10.1016/0264-410x(90)90161-e. Vaccine. 1990. PMID: 2336878 No abstract available.

6

[Oral vaccines against poliomyelitis and vaccination-related paralytic poliomyelitis in Germany. Do we need a new immunization strategy?].

Fescharek R, Arras-Reiter C, Arens ER, Quast U, Maass G. Fescharek R, et al. Wien Med Wochenschr. 1997;147(19-20):456-61. Wien Med Wochenschr. 1997. PMID: 9471843 German.

7

Do anaesthetics and surgical stress increase the risk of post-exposure rabies treatment failure?

Fescharek R, Franke V, Samuel MR. Fescharek R, et al. Vaccine. 1994 Jan;12(1):12-3. doi: 10.1016/0264-410x(94)90004-3. Vaccine. 1994. PMID: 7864909

8

Alert systems for post-marketing surveillance of adverse drug reactions.

Praus M, Schindel F, Fescharek R, Schwarz S. Praus M, et al. Among authors: fescharek r. Stat Med. 1993 Dec 30;12(24):2383-93. doi: 10.1002/sim.4780122414. Stat Med. 1993. PMID: 8134741

9

Postexposure rabies prophylaxis: when the guidelines are not respected.

Fescharek R, Schwarz S, Quast U, Gandhi N, Karkhanis S. Fescharek R, et al. Vaccine. 1991 Dec;9(12):868-72. doi: 10.1016/0264-410x(91)90005-q. Vaccine. 1991. PMID: 1811373

10

Postexposure rabies vaccination during pregnancy: experience from post-marketing surveillance with 16 patients.

Fescharek R, Quast U, Dechert G. Fescharek R, et al. Vaccine. 1990 Aug;8(4):409. doi: 10.1016/0264-410x(90)90120-b. Vaccine. 1990. PMID: 2278557 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

20 results

Search Page

Filters